HR 4792 117th Congress House International Affairs Animal protection and human-animal relationships Arms control and nonproliferation Asia Business expenses Business investment and capital Cardiovascular and respiratory health Cell biology and embryology Chemical and biological weapons China Civil actions and liability Congressional committees Congressional operations and organization Congressional oversight Criminal investigation, prosecution, interrogation Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Employee hiring Espionage and treason Europe

Countering Communist China Act

Introduced: July 29, 2021 Introduced by: Banks, Jim Republican · Indiana See on congress.gov

Everywhere this bill has been 7 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 3, 2021

Referred to the Subcommittee on Energy and Mineral Resources.

Aug 4, 2021

Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.

Jul 30, 2021

Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.

Jul 30, 2021

Referred to the Subcommittee on Health.

Jul 29, 2021

Referred to the Subcommittee on Trade.

Jul 29, 2021

Referred to the Committee on Foreign Affairs, and in addition to the Committees on the Judiciary, Ways and Means, Oversight and Reform, Financial Services, Energy and Commerce, Intelligence (Permanent Select), Agriculture, Rules, Transportation and Infrastructure, Science, Space, and Technology, Natural Resources, Education and Labor, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jul 29, 2021

Introduced in House

Plain-English summary Congressional Research Service

Countering Communist China Act

This bill addresses issues related to China, tax incentives, and other topics.

The bill imposes visa- and property-blocking sanctions on certain entities and individuals that (1) are involved in acts of malign disinformation on behalf of a foreign government or political party, or (2) have engaged in a pattern of significant infringement of intellectual property belonging to a U.S. entity or individual. It also authorizes sanctions on developers and owners of software that makes unauthorized transmissions of user data to servers that are located in China and are accessible by China's government.

The bill also

provides tax incentives for relocating pharmaceutical, medical supply, or medical device manufacturing to the United States, including by allowing accelerated depreciation of nonresidential real property acquired in connection with such relocation;
eliminates the five-year amortization requirement for research and experimental expenditures scheduled to begin in 2022, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred;
prohibits an institution of higher education from receiving certain federal funds if the institution has a contractual partnership with an entity controlled by China's government or organized under China's laws;
modifies presumptions and evidentiary standards in administrative patent validity challenges;
bars China from asserting sovereign immunity in certain instances;
requires U.S. representatives to the International Monetary Fund (IMF) to take certain actions, such as opposing any increase to the weight given to China's currency when determining the value of IMF Special Drawing Rights; and
permanently rescinds unobligated funds previously made available for certain economic relief programs related to COVID-19.